Pre-treatment evaluation of FRET-based drug sensitivity test for patients with CML treated with dasatinib. Kondo T, et al, Cancer Sci. 109(7): 2256-2265, 2018 | What's new | Bringing light to every patient’s future | Horizon IlluminationLab Optics

2021.02.18

Pre-treatment evaluation of FRET-based drug sensitivity test for patients with CML treated with dasatinib. Kondo T, et al, Cancer Sci. 109(7): 2256-2265, 2018

For more details, click here.

ARCHIVE

2021

2